BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PTOHD - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PTOHD
X-ORIGINAL-URL:https://ptohd.pl
X-WR-CALDESC:Wydarzenia dla PTOHD
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Warsaw
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Warsaw:20240619T160000
DTEND;TZID=Europe/Warsaw:20240619T173000
DTSTAMP:20260418T191452
CREATED:20240617T121933Z
LAST-MODIFIED:20240617T123143Z
UID:2745-1718812800-1718818200@ptohd.pl
SUMMARY:Update on CAR T-cell therapy on paediatric leukemia
DESCRIPTION:Approaches to managing early loss of CAR T persistence in ALL – Sara Ghorashian\,\n \n 	CAR T-cell therapy for AML- state of the art – Tobias Feuchtinger\,\n \n 	Variables impacting outcome of CAR T-cell therapy for paediatric ALL – Liora Schultz.\n\nYou may register – free of charge – on the EBMT homepage.Dear all\,\n\nit is our great pleasure to announce two exciting events from the PDWP in the field of CAR T cells therapy:\n\nFirst\, we will host an e-learning webinar on June 19th\, 16:00-17:30 CEST\, entitled “Update on CAR T-cell therapy on paediatric leukemia”\, which provides an update of the state-of-the-art for CAR T-cell therapy for paediatric leukaemia and addresses the key issues in this field. This webinar is suitable for both paediatric and adult physicians/trainees with an interest in CAR T-cell therapy.\n\nModerators will be Persis Amrolia\, Matthias Eyrich and Jochen Büchner\, discussing with the speakers:\n\n\n\n 	Approaches to managing early loss of CAR T persistence in ALL – Sara Ghorashian\,\n \n 	CAR T-cell therapy for AML- state of the art – Tobias Feuchtinger\,\n \n 	Variables impacting outcome of CAR T-cell therapy for paediatric ALL – Liora Schultz.\n\nYou may register – free of charge – on the EBMT homepage.
URL:https://ptohd.pl/wydarzenie/update-on-car-t-cell-therapy-on-paediatric-leukemia-szkolenie-ebmt/
END:VEVENT
END:VCALENDAR